P-141PanCO: An open-label, single-arm pilot study of Oncosil™ in patients with unresectable locally advanced pancreatic adenocarcinoma in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies
Harris, M, Croagh, D, Aghmesheh, M, Nagrial, A, Nguyen, N, Wasan, H, Ajithkumar, T, Kraszewski, A, Maher, T, Ross, PVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy151.140
Date:
June, 2018
File:
PDF, 69 KB
english, 2018